American Venous Forum and American Venous and Lymphatic Society

Non-pneumatic compression and its clinical utility in management of lymphedema. A position statement endorsed by the American Venous Forum and the American Venous and Lymphatic Society

2026United States

Ce document comprend 2 recommandations et 26 références.

Contenu en anglais

Lire la recommandation officielleInterroger Osler sur cette recommandation

Synthèse

This position statement, endorsed by the American Venous Forum (AVF) and the American Venous and Lymphatic Society (AVLS), assesses the clinical utility of non-pneumatic compression devices (NPCDs) in managing lymphedema and phlebolymphedema. NPCDs use shape-memory alloys (nitinol) to deliver programmable sequential gradient compression while enabling patient mobility. The statement reviews clinical evidence, including two randomized controlled trials (NILE and TEAYS) which show NPCD's superiority over advanced pneumatic compression devices (PCDs) regarding volume reduction, quality of life, and treatment adherence.

Posez une question sur cette recommandation.

Osler répond à partir de cette bibliothèque et cite la recommandation derrière chaque affirmation.

Découvrir Osler

Lymphedema is an incurable chronic swelling condition caused by impaired lymphatic drainage, affecting 5 to 10 million people in the U.S. Phlebolymphedema, stemming from chronic venous insufficiency, is a major subtype. While conservative therapy and pneumatic compression devices (PCDs) are standard, PCDs are limited by patient immobilization and low adherence. Non-pneumatic compression devices (NPCDs) address these gaps by supporting mobility and active muscle pump contraction during therapy.

Messages clés

Lymphedema is an underdiagnosed and undertreated chronic condition, with phlebolymphedema being a major subtype representing 41.8% of lower extremity cases.
NPCD offers a multi-modal alternative to PCDs by combining static compression, gradient sequential compression (0-100 mmHg), and muscle pump activation by enabling patient mobility.
In two multi-center RCTs (NILE and TEAYS), NPCD demonstrated superior results over advanced PCDs, including higher volume reduction, better quality of life (LYMQOL), and higher patient-reported adherence.
NPCD has active HCPCS billing codes (E0680, E0678, E0679, E0682) established by CMS, recognizing its therapeutically distinct mechanism of action.

Recommandations

NON-PNEUMATIC COMPRESSION TREATMENT

Treating chronic venous insufficiency (CVI) (CEAP C3-C6) as lymphedema to improve management outcomes.
Patients concernés: Patients with chronic venous insufficiency (CEAP C3-C6)Situation: Chronic venous insufficiency
RecommendedTreatment

CONCLUSIONS

Non-pneumatic compression (NPCD) should be considered after conservative treatment failure and included in future guideline assessments.
Patients concernés: Patients with lymphedema, phlebolymphedema, and related conditionsSituation: Lymphedema, phlebolymphedema, or related conditions failing conservative treatment
Treatment

Champ d’application et patients concernés

Thème clinique

Lymphedema and phlebolymphedema management using non-pneumatic compression devices (NPCDs)

Objectifs

To review and evaluate the clinical evidence, design, mechanisms of action, and clinical utility of non-pneumatic compression devices (NPCDs) in the management of lymphedema and phlebolymphedema.

Population de patients

Patients with lymphedema, phlebolymphedema, chronic venous insufficiency (CVI), lipedema, or chronic edema-related conditions.

Inclus

Lymphedema
Phlebolymphedema
Venous insufficiency
Lipedema
Chronic edema-related conditions

Exclus

Active cellulitis
Skin ulceration
Impaired ambulation capability

Professionnels concernés

Vascular surgeons
Lymphatic specialists
Phlebologists
Physicians
Physical therapists

Contextes de soins

Clinic
Home

Populations particulières

Older adults (65 or greater)
Device-naïve patients

Sécurité

Contre-indications

Active cellulitis
Skin ulceration

Surveillance

Monitor for localized skin irritation and patient compliance; evaluate benefit in patients with impaired ambulation.

Définitions

Lymphedema: A chronic, incurable condition caused by impaired lymphatic drainage, leading to progressive swelling and functional impairment.
Phlebolymphedema: A subtype of lymphedema linked to chronic venous insufficiency (CVI), where elevated venous pressure disrupts lymphatic function.
Pneumatic compression devices (PCDs): Compression devices utilizing stationary air compressors or air-inflated sleeves with programmable pumps and sequential inflation/deflation of multi-chamber garments.
Non-pneumatic compression device (NPCD): A device that integrates static compression, sequential gradient compression (distal to proximal), and muscle pump activation using electromechanical actuators with nitinol (a shape memory alloy) to enable active movement during treatment.

Pour apprendre

Dans cette recommandation

Groupe de travail pluridisciplinaire

Niveau

Intermediate

Parcours d’apprentissage

Vascular Medicine
Lymphatic Disease
Lymphedema Management
Compression Therapy
Medical Devices

Prognia résume cette recommandation à des fins de consultation et d’enseignement. Il ne s’agit pas d’un avis médical. Vérifiez toujours la recommandation officielle et les protocoles locaux en vigueur avant de l’appliquer.

Résumé audio

Une présentation orale de cette recommandation.

0:000:00

Supports pédagogiques

En bref

Organisme: American Venous Forum and American Venous and Lymphatic Society
Date de publication: 1 mars 2026
Région: United States
Langue: English
DOI: 10.1016/j.jvsv.2025.102356
Ajout sur Prognia: 26 juillet 2026

Mots-clés

Lymphedema
Phlebolymphedema
Compression Therapy
Non-pneumatic compression devices
NPCDs
American Venous Forum
American Venous and Lymphatic Society
AVF
AVLS
Vascular Surgery
Guidelines
Recommendations
Intermittent Pneumatic Compression Devices